주식/증권
📈 긍정적
Johnson & Johnson Hikes Earnings Guidance but Pharma Growth Masks a MedTech Stumble. Stock Falls.
요약
Johnson & Johnson says it is working to improve results in its medical-device business, where surgery revenue fell for the latest quarter.